Patents Assigned to Vitateq Biotechnology GmbH
  • Method for Diagnosing Preeclampsia
    Publication number: 20140127703
    Abstract: Described is a method for in vitro diagnosing whether a pregnant woman has a risk for developing preeclampsia (PE) comprising the steps of determining the afamin content of the pregnant woman in a blood sample or a blood-derived sample, urine, amniotic and cerebrospinal fluid; or determining the content of afamin m-RNA in a liver tissue sample; and comparing the afamin content determined in the sample with a reference value.
    Type: Application
    Filed: June 28, 2012
    Publication date: May 8, 2014
    Applicant: VITATEQ BIOTECHNOLOGY GMBH
    Inventors: Hans Dieplinger, Hannes Buchner, Christian Wadsack, Ludwig Wildt, Benjamin Dieplinger
  • Method for diagnosing tumors
    Patent number: 8129129
    Abstract: The present invention describes a method for diagnosing tumors of the reproductive organs which is characterized by determination of the afamin content in a sample of a body fluid or in a tissue sample, wherein a tumor is diagnosed if the afamin content in the sample is decreased compared to the afamin content in a sample from a person without a tumor of the reproductive organs.
    Type: Grant
    Filed: March 12, 2010
    Date of Patent: March 6, 2012
    Assignee: Vitateq Biotechnology GmbH
    Inventor: Hans Dieplinger
  • Use of Afamin for Treating Fertility Disorders
    Publication number: 20110179509
    Abstract: The invention relates to the use of afamin for the manufacture of a pharmaceutical preparation for the prevention or treatment of fertility disorders.
    Type: Application
    Filed: October 1, 2009
    Publication date: July 21, 2011
    Applicant: VITATEQ BIOTECHNOLOGY GMBH
    Inventors: Hans Dieplinger, Wolfgang Engel, Georg Wietzorrek
  • Method of diagnosing early stage renal impairment
    Patent number: 7842463
    Abstract: There is disclosed a method of diagnosing early stage renal impairment in humans, characterized by the following steps: measuring the amount of apoA-IV in a body liquid or tissue sample of a human, and comparing the measured amount of apoA-IV with a reference value.
    Type: Grant
    Filed: July 23, 2002
    Date of Patent: November 30, 2010
    Assignee: Vitateq Biotechnology Gmbh
    Inventor: Florian Kronenberg
  • Method for diagnosing tumors
    Patent number: 7767406
    Abstract: The present invention describes a method for diagnosing tumours of the reproductive organs which is characterised by determination of the afamin content in a sample of a body fluid or in a tissue sample, wherein a tumour is diagnosed if the afamin content in the sample is decreased compared to the afamin content in a sample from a person without a tumour of the reproductive organs.
    Type: Grant
    Filed: January 31, 2006
    Date of Patent: August 3, 2010
    Assignee: Vitateq Biotechnology GmbH
    Inventor: Hans Dieplinger
  • Method for Diagnosing Tumors by Measuring the Level of Apolipoprotein A-IV
    Publication number: 20100136583
    Abstract: Method for diagnosing a tumor in an individual comprising the following steps: —measuring the amount of apolipoprotein A-IV (ApoA-IV) in a body fluid sample or tissue sample of an individual, —comparing the measured amount of ApoA-IV in said sample with a reference value, wherein the reference value is the ApoA-IV content in a sample derived from an individual without a tumor, and —diagnosing a tumor if the ApoA-IV content in the sample is decreased compared to the reference value.
    Type: Application
    Filed: August 8, 2006
    Publication date: June 3, 2010
    Applicant: VITATEQ BIOTECHNOLOGY GMBH
    Inventors: Hans Dieplinger, Florian Kronenberg
  • Method For Diagnosing Tumors
    Publication number: 20080166737
    Abstract: The present invention describes a method for diagnosing tumours of the reproductive organs which is characterised by determination of the afamin content in a sample of a body fluid or in a tissue sample, wherein a tumour is diagnosed if the afamin content in the sample is decreased compared to the afamin content in a sample from a person without a tumour of the reproductive organs.
    Type: Application
    Filed: January 31, 2006
    Publication date: July 10, 2008
    Applicant: Vitateq Biotechnology GmbH
    Inventor: Hans Dieplinger
  • Method for determining the fertility of mammals, especially humans
    Patent number: 6762033
    Abstract: Disclosed is a method for determining the fertility of mammals, in particular of humans, wherein a body or organ fluid is taken from a mammal, the afamin content is determined in this body or organ fluid, and the determined afamin content is compared with a reference value so as to determine the fertility, the use of afamin for determining the fertility of mammals, as well as a kit for carrying out this method.
    Type: Grant
    Filed: December 21, 2001
    Date of Patent: July 13, 2004
    Assignee: Vitateq Biotechnology GmbH
    Inventors: Karl Oskar Illmensee, Hans Dieplinger
  • Method for determining the fertility of mammals, especially of humans
    Publication number: 20020137100
    Abstract: Disclosed is a method for determining the fertility of mammals, in particular of humans, wherein
    Type: Application
    Filed: March 22, 2002
    Publication date: September 26, 2002
    Applicant: Vitateq Biotechnology GMBH
    Inventors: Karl Oskar Illmensee, Hans Dieplinger